A phase II study of perioperative cadonilimab (AK104) in patients with recurrent resectable head and neck squamous cell carcinoma.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lei Liu, Jun Wang, Yi Li, Fei Chen, Bing Yan, Yuanyuan Zeng, Zhongzheng Xiang
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162503787
Cites:
Cited by:
Related to:
